Sinovant Sciences is an innovative biopharmaceutical company based in Shanghai, Beijing and Hong Kong. Sinovant was founded by Chinese scientists and physicians, including Chinese “Returnees”. Sinovant is uniquely positioned to bring cutting-edge global medical innovation to China, and transformative Chinese medical innovation to the world.
Sinovant has a diverse pipeline of 13 investigational products in development, among which 5 drug candidates are in phase III or beyond. Our products span over 8 therapeutic areas including oncology, infectious disease, urology, metabolic disease, pulmonary disease, gastroenterology, dermatology and rare diseases.